about
A strategy of tumor treatment in mice with doxorubicin-cyclophosphamide combination based on dendritic cell activation by human double-stranded DNA preparation.Combination of cyclophosphamide and double-stranded DNA demonstrates synergistic toxicity against established xenografts.Properties of internalization factors contributing to the uptake of extracellular DNA into tumor-initiating stem cells of mouse Krebs-2 cell line.A strategy to eradicate well-developed Krebs-2 ascites in miceGene expression profiling of tumor-initiating stem cells from mouse Krebs-2 carcinoma using a novel marker of poorly differentiated cellsComparative analysis of pathologic processes developing in mice housed in SPF vs non-SPF conditions and treated with cyclophosphamide and dsDNA preparation.Identification of cancer stem cells and a strategy for their elimination.Novel Cancer Stem Marker and Its Applicability for Grading Primary Human Gliomas.Delivery and processing of exogenous double-stranded DNA in mouse CD34+ hematopoietic progenitor cells and their cell cycle changes upon combined treatment with cyclophosphamide and double-stranded DNA.Efficacy of a new cancer treatment strategy based on eradication of tumor-initiating stem cells in a mouse model of Krebs-2 solid adenocarcinoma.Cancer Stem Cells: Emergent Nature of Tumor EmergencyIdentification of the xenograft and its ascendant sphere-forming cell line as belonging to EBV-induced lymphoma, and characterization of the status of sphere-forming cells"Delayed death" phenomenon: a synergistic action of cyclophosphamide and exogenous DNAEffect of double-stranded DNA on maturation of dendritic cells in vitroUltrastructural analysis of the Krebs-2 ascites cancer cells treated with extracellular double-stranded DNA preparation
P50
Q34330865-88432B8E-C08D-4E21-BB43-8FAD63DEDE87Q35204204-00E37C17-1AD7-4F32-A4BC-93775AF9B94DQ36938161-3972DD37-ED71-42D5-AF44-35747C01E421Q36998311-AE1D36BC-B9DD-4DE9-A94A-477EBA0CAABCQ39056377-BF181B64-E76B-4A9C-AF14-7373FBE5F0CEQ41040823-9E19EC23-4F3E-40FC-911A-DB72F78384C5Q41832042-A93F6987-190B-43C4-8153-2959CD2A2B97Q47836853-62B3CC62-13E4-4AD2-8014-EFE05A27E343Q53095961-DBA8BA8D-F99A-4F13-A409-CD6F022A1AD6Q55452001-1C83A1E4-D411-4D5E-8605-DC2562D7BBC9Q59798121-E0713A55-378B-4C53-A029-11FD0C1DC8F5Q64065209-A122C149-13C0-4410-B22A-053CF83536B4Q64386585-CD8805D5-0956-42FC-A5DE-75A964703638Q85071860-8807C9B6-3CD3-4883-B857-B040956777C5Q91538556-DF911939-48AB-4E9F-9BFC-E4EB26BCAF2C
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Yaroslav R Efremov
@ast
Yaroslav R Efremov
@en
Yaroslav R Efremov
@es
Yaroslav R Efremov
@nl
type
label
Yaroslav R Efremov
@ast
Yaroslav R Efremov
@en
Yaroslav R Efremov
@es
Yaroslav R Efremov
@nl
prefLabel
Yaroslav R Efremov
@ast
Yaroslav R Efremov
@en
Yaroslav R Efremov
@es
Yaroslav R Efremov
@nl
P106
P1153
36598162200
P31
P496
0000-0002-0649-7543